FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225962005> ?p ?o ?g. }

• W4225962005 endingPage "970" @default.
• W4225962005 startingPage "962" @default.
• W4225962005 abstract "The risk-to-benefit profile of treating an unruptured high-grade dural arteriovenous fistula (dAVF) is not clearly defined. The aim of this multicenter retrospective cohort study was to compare the outcomes of different interventions with observation for unruptured high-grade dAVFs.The authors retrospectively reviewed dAVF patients from 12 institutions participating in the Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR). Patients with unruptured high-grade (Borden type II or III) dAVFs were included and categorized into four groups (observation, embolization, surgery, and stereotactic radiosurgery [SRS]) based on the initial management. The primary outcome was defined as the modified Rankin Scale (mRS) score at final follow-up. Secondary outcomes were good outcome (mRS scores 0-2) at final follow-up, symptomatic improvement, all-cause mortality, and dAVF obliteration. The outcomes of each intervention group were compared against those of the observation group as a reference, with adjustment for differences in baseline characteristics.The study included 415 dAVF patients, accounting for 29, 324, 43, and 19 in the observation, embolization, surgery, and SRS groups, respectively. The mean radiological and clinical follow-up durations were 21 and 25 months, respectively. Functional outcomes were similar for embolization, surgery, and SRS compared with observation. With observation as a reference, obliteration rates were higher after embolization (adjusted OR [aOR] 7.147, p = 0.010) and surgery (aOR 33.803, p < 0.001) and all-cause mortality was lower after embolization (imputed, aOR 0.171, p = 0.040). Hemorrhage rates per 1000 patient-years were 101 for observation versus 9, 22, and 0 for embolization (p = 0.022), surgery (p = 0.245), and SRS (p = 0.077), respectively. Nonhemorrhagic neurological deficit rates were similar between each intervention group versus observation.Embolization and surgery for unruptured high-grade dAVFs afforded a greater likelihood of obliteration than did observation. Embolization also reduced the risk of death and dAVF-associated hemorrhage compared with conservative management over a modest follow-up period. These findings support embolization as the first-line treatment of choice for appropriately selected unruptured Borden type II and III dAVFs." @default.
• W4225962005 created "2022-05-05" @default.
• W4225962005 creator A5010496038 @default.
• W4225962005 creator A5013652245 @default.
• W4225962005 creator A5020200536 @default.
• W4225962005 creator A5023093297 @default.
• W4225962005 creator A5029613368 @default.
• W4225962005 creator A5034637646 @default.
• W4225962005 creator A5035302435 @default.
• W4225962005 creator A5037307510 @default.
• W4225962005 creator A5037367242 @default.
• W4225962005 creator A5038571038 @default.
• W4225962005 creator A5038924268 @default.
• W4225962005 creator A5040105263 @default.
• W4225962005 creator A5041533304 @default.
• W4225962005 creator A5043226851 @default.
• W4225962005 creator A5043879863 @default.
• W4225962005 creator A5051773233 @default.
• W4225962005 creator A5053752894 @default.
• W4225962005 creator A5057368505 @default.
• W4225962005 creator A5057716113 @default.
• W4225962005 creator A5058905474 @default.
• W4225962005 creator A5059303705 @default.
• W4225962005 creator A5062397023 @default.
• W4225962005 creator A5066810919 @default.
• W4225962005 creator A5068016958 @default.
• W4225962005 creator A5068894728 @default.
• W4225962005 creator A5070057851 @default.
• W4225962005 creator A5070619742 @default.
• W4225962005 creator A5075287421 @default.
• W4225962005 creator A5078938709 @default.
• W4225962005 creator A5080595395 @default.
• W4225962005 creator A5085188789 @default.
• W4225962005 creator A5089204541 @default.
• W4225962005 creator A5091571323 @default.
• W4225962005 date "2022-04-01" @default.
• W4225962005 modified "2023-10-11" @default.
• W4225962005 title "Intervention for unruptured high-grade intracranial dural arteriovenous fistulas: a multicenter study" @default.
• W4225962005 cites W1513288543 @default.
• W4225962005 cites W1606032174 @default.
• W4225962005 cites W1963514612 @default.
• W4225962005 cites W1992981841 @default.
• W4225962005 cites W2002973089 @default.
• W4225962005 cites W2057169470 @default.
• W4225962005 cites W2065400074 @default.
• W4225962005 cites W2073203085 @default.
• W4225962005 cites W2089026545 @default.
• W4225962005 cites W2110124299 @default.
• W4225962005 cites W2118248658 @default.
• W4225962005 cites W2118502261 @default.
• W4225962005 cites W2121555254 @default.
• W4225962005 cites W2138322193 @default.
• W4225962005 cites W2138479739 @default.
• W4225962005 cites W2150689557 @default.
• W4225962005 cites W2153102530 @default.
• W4225962005 cites W2169145798 @default.
• W4225962005 cites W2512909584 @default.
• W4225962005 cites W2516097488 @default.
• W4225962005 cites W2588357528 @default.
• W4225962005 cites W2605490541 @default.
• W4225962005 cites W2618753514 @default.
• W4225962005 cites W2786023776 @default.
• W4225962005 cites W2791504420 @default.
• W4225962005 cites W2803814147 @default.
• W4225962005 doi "https://doi.org/10.3171/2021.1.jns202799" @default.
• W4225962005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34608140" @default.
• W4225962005 hasPublicationYear "2022" @default.
• W4225962005 type Work @default.
• W4225962005 citedByCount "5" @default.
• W4225962005 countsByYear W42259620052022 @default.
• W4225962005 countsByYear W42259620052023 @default.
• W4225962005 crossrefType "journal-article" @default.
• W4225962005 hasAuthorship W4225962005A5010496038 @default.
• W4225962005 hasAuthorship W4225962005A5013652245 @default.
• W4225962005 hasAuthorship W4225962005A5020200536 @default.
• W4225962005 hasAuthorship W4225962005A5023093297 @default.
• W4225962005 hasAuthorship W4225962005A5029613368 @default.
• W4225962005 hasAuthorship W4225962005A5034637646 @default.
• W4225962005 hasAuthorship W4225962005A5035302435 @default.
• W4225962005 hasAuthorship W4225962005A5037307510 @default.
• W4225962005 hasAuthorship W4225962005A5037367242 @default.
• W4225962005 hasAuthorship W4225962005A5038571038 @default.
• W4225962005 hasAuthorship W4225962005A5038924268 @default.
• W4225962005 hasAuthorship W4225962005A5040105263 @default.
• W4225962005 hasAuthorship W4225962005A5041533304 @default.
• W4225962005 hasAuthorship W4225962005A5043226851 @default.
• W4225962005 hasAuthorship W4225962005A5043879863 @default.
• W4225962005 hasAuthorship W4225962005A5051773233 @default.
• W4225962005 hasAuthorship W4225962005A5053752894 @default.
• W4225962005 hasAuthorship W4225962005A5057368505 @default.
• W4225962005 hasAuthorship W4225962005A5057716113 @default.
• W4225962005 hasAuthorship W4225962005A5058905474 @default.
• W4225962005 hasAuthorship W4225962005A5059303705 @default.
• W4225962005 hasAuthorship W4225962005A5062397023 @default.
• W4225962005 hasAuthorship W4225962005A5066810919 @default.
• W4225962005 hasAuthorship W4225962005A5068016958 @default.
• W4225962005 hasAuthorship W4225962005A5068894728 @default.
• W4225962005 hasAuthorship W4225962005A5070057851 @default.

• next